A Prospective, Randomized, Two Period, With an Intermediate Wash Out Period, Cross-over Study to Compare the Effects of Either Combined Therapy With Ramipril and Clopidogrel or Ramipril Monotherapy on Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Patients With Type 2 Diabetes and Diabetic Nephropathy
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Clopidogrel (Primary) ; Ramipril (Primary)
- Indications Cardiovascular disorders; Diabetic nephropathies; Embolism and thrombosis; Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 10 Jan 2013 New trial record